Company: PHR
Filing Date: 2025-12-09
Form Type: 10-Q
Source: 0001412408-25-000132
Chunk: 130

Company: Phreesia, Inc.
Filing Date: 2025-12-09
Form: 10-Q
Item: Part I, Item 1
Chunk 130
---
 and related services$55,480 $49,363 $6,117 12 %Payment processing fees27,422 24,704 2,718 11 %Network solutions37,431 32,733 4,698 14 %Total revenue$120,333 $106,800 $13,533 13 %

•Subscription and related services. Our subscription and related services revenue from healthcare services organizations increased $6.1 million to $55.5 million for the three months ended October 31, 2025, as compared to $49.4 million for the three months ended October 31, 2024, primarily due to new healthcare services clients as well as expansion of and cross-selling to existing healthcare services clients.

•Payment processing fees. Our revenue from patient payments processed through our solutions increased $2.7 million to $27.4 million for the three months ended October 31, 2025, as compared to $24.7 million for the three months ended October 31, 2024, due to the addition of new healthcare services clients, which drove increases in patient visits and patient payments processed through our platform.

•Network solutions. Our revenue from life sciences companies and other organizations increased $4.7 million to $37.4 million for the three months ended October 31, 2025, as compared to $32.7 million for the three months ended October 31, 2024, due to an increase in engagement, education programs and deeper patient outreach among the existing programs.

 Nine months endedOctober 31, ($ in thousands)20252024$ Change% ChangeSubscription and related services$163,537 $144,717 $18,820 13 %Payment processing fees85,739 77,064 8,675 11 %Network solutions104,248 88,351 15,897 18 %Total revenue$353,524 $310,132 $43,392 14 %

•Subscription and related services. Our subscription and related services revenue from healthcare services organizations increased $18.8 million to $163.5 million for the nine months ended October 31, 2025, as compared to $144.7 million for the nine months ended October 31, 2024, primarily due to new healthcare services clients as well as expansion of and cross-selling to existing healthcare services clients.

•Payment processing fees. Our revenue from patient payments